Gilead Sciences Inc
XHAM:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
XHAM:GIS
|
US |
|
A
|
ADES Holding Company SJSC
SAU:2382
|
SA |
|
A
|
Addus Homecare Corp
XBER:A41
|
US |
|
Root Inc
NASDAQ:ROOT
|
US |
|
N
|
Nordstrom Inc
SWB:NRD
|
US |
|
Universal Scientific Industrial Shanghai Co Ltd
SSE:601231
|
CN |
|
M
|
McCormick & Company Inc
DUS:MCX
|
US |
|
W
|
Wharf Holdings Ltd
OTC:WARFF
|
HK |
Wall St Price Targets
GIS Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for GIS is 138.21 EUR with a low forecast of 105.48 EUR and a high forecast of 161.78 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIS's stock price target?
Price Target
138.21
EUR
According to Wall Street analysts, the average 1-year price target for GIS is 138.21 EUR with a low forecast of 105.48 EUR and a high forecast of 161.78 EUR.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.
